Medication errors are an important cause of iatrogenic morbidity and mortality. There is limited evidence to indicate that
children may be more vulnerable to medication errors because of the need for a weight-based dosing approach and the
increased sensitivity of children to relatively small dosing errors. Polypharmacy, the lack of effective communication between
children and healthcare personnel as well as prescribing errors for example incomplete or illegible prescription, incorrect route
or incorrect intravenous infusion are common errors. Off-label or unlicensed use in pediatric population also contribute to
medication errors. As medication errors are preventable errors, these require special attention. Multifaceted interventions
including all members of healthcare team, i.e. physician, nurses, pharmacists as well caretakers are required. Interventions
to prevent medication errors include computerization of prescriptions, electronic medical records, voluntary and triggered
reporting. As the incidence and type of medication errors vary widely with hospitals, local evaluation of the type, frequency
and root cause of various medication errors as well as customization of corrective measures may be desirable. Magnitude of
medication errors in pediatric population, their impact on society and interventions to reduce medication errors have been
discussed in this presentation.
Deepa Arora is a Physician having more than 15 years of experience in drug safety and clinical development in pharma industry and in academia. She
has been in leadership and strategic roles in MNCs and Indian Pharma companies and successfully set up systems, developed teams and interacted
with regulatory agencies in different regions including US, Europe, India and Australia. She has played an active role in developing awareness
and skills of pharmacovigilance in the region by designing teaching modules for safety in medical institutions and training in pharmacovigilance
workshops and courses. She is the author of the book ?Pharmacovigilance- An Industry Perspective?.
She is working with Lupin Limited as the Global Head- Drug Safety & Risk Management.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals